Sionna Therapeutics (NASDAQ:SION), a clinical-stage biopharma focused on developing cystic fibrosis therapies, opened well above its initial public offering price on Friday in its first trading ...
Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...
The increasing need for airway clearance devices for cystic fibrosis is largely fueled by the rising prevalence of the disease, a growing num ...
Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...
On Thursday, Ella’s Niskayuna/Schenectady team faced off against Ava’s Shaker squad in a dual meet, with the Blue Bison ...
Power has now been restored to over 215,000 properties. Speaking on Good Morning Ulster, Ronan McKeown, NIE future networks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback